Karla Kopec

447 total citations
10 papers, 306 citations indexed

About

Karla Kopec is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Karla Kopec has authored 10 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Physiology. Recurrent topics in Karla Kopec's work include Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (4 papers) and Amino Acid Enzymes and Metabolism (2 papers). Karla Kopec is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (4 papers) and Amino Acid Enzymes and Metabolism (2 papers). Karla Kopec collaborates with scholars based in United States. Karla Kopec's co-authors include Richard T. Carroll, Edward D. Hall, John S. Althaus, Paul Galatsis, Donna Bozyczko‐Coyne, Michael Williams, Mark A. Ator, John T. Durkin, Joseph M. Salvino and Sheryl L. Meyer and has published in prestigious journals such as Biochemistry, Brain Research and Journal of Neurochemistry.

In The Last Decade

Karla Kopec

10 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karla Kopec United States 6 132 109 86 42 39 10 306
Marlena Zyśk Poland 11 155 1.2× 159 1.5× 68 0.8× 36 0.9× 20 0.5× 21 341
John Flax United States 5 243 1.8× 184 1.7× 54 0.6× 27 0.6× 24 0.6× 9 441
Ceyhan Elipenahli United States 6 181 1.4× 224 2.1× 83 1.0× 88 2.1× 19 0.5× 6 375
Chihiro Tamaki Japan 7 133 1.0× 179 1.6× 36 0.4× 32 0.8× 22 0.6× 8 391
Vera Maria Treis Trindade Brazil 15 248 1.9× 168 1.5× 34 0.4× 70 1.7× 64 1.6× 41 540
Pei‐Chuan Ho Taiwan 10 252 1.9× 185 1.7× 53 0.6× 49 1.2× 24 0.6× 13 510
Rafael Gonzalo‐Gobernado Spain 13 143 1.1× 55 0.5× 85 1.0× 121 2.9× 26 0.7× 25 428
Simon Heales United Kingdom 6 177 1.3× 220 2.0× 53 0.6× 50 1.2× 11 0.3× 8 416
Ana C. Valencia‐Olvera United States 9 110 0.8× 142 1.3× 55 0.6× 52 1.2× 14 0.4× 14 339
Yun‐An Lim Australia 4 266 2.0× 134 1.2× 127 1.5× 34 0.8× 51 1.3× 5 437

Countries citing papers authored by Karla Kopec

Since Specialization
Citations

This map shows the geographic impact of Karla Kopec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla Kopec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla Kopec more than expected).

Fields of papers citing papers by Karla Kopec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla Kopec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla Kopec. The network helps show where Karla Kopec may publish in the future.

Co-authorship network of co-authors of Karla Kopec

This figure shows the co-authorship network connecting the top 25 collaborators of Karla Kopec. A scholar is included among the top collaborators of Karla Kopec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla Kopec. Karla Kopec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dunn, Derek, et al.. (2014). Lactam and oxazolidinone derived potent 5-hydroxytryptamine 6 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 24(9). 2094–2097. 2 indexed citations
2.
Kopec, Karla, Dorothy G. Flood, Maciej Gąsior, et al.. (2010). Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice. Biochemical Pharmacology. 80(9). 1407–1417. 27 indexed citations
3.
Durkin, John T., et al.. (2010). Amino-terminal isoforms of the human glycine transporter GlyT1 exhibit similar pharmacology. Brain Research. 1374. 1–7. 2 indexed citations
4.
Kopec, Karla, et al.. (2009). Successful Identification of Glycine Transporter Inhibitors Using an Adaptation of a Functional Cell-Based Assay. SLAS DISCOVERY. 14(10). 1185–1194. 4 indexed citations
5.
Kopec, Karla, Donna Bozyczko‐Coyne, & Michael Williams. (2005). Target identification and validation in drug discovery: the role of proteomics. Biochemical Pharmacology. 69(8). 1133–1139. 37 indexed citations
6.
Kopec, Karla, et al.. (2005). A Homogeneous Assay to Assess GABA Transporter Activity. Current Protocols in Pharmacology. 30(1). Unit1.32–Unit1.32. 2 indexed citations
7.
Durkin, John T., Beverly P. Holskin, Karla Kopec, et al.. (2004). Phosphoregulation of Mixed-Lineage Kinase 1 Activity by Multiple Phosphorylation in the Activation Loop. Biochemistry. 43(51). 16348–16355. 20 indexed citations
8.
Kopec, Karla & Richard T. Carroll. (2000). Phagocytosis is Regulated by Nitric Oxide in Murine Microglia. Nitric Oxide. 4(2). 103–111. 41 indexed citations
9.
Carroll, Richard T., et al.. (2000). 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol) Inhibits Peroxynitrite-Mediated Phenol Nitration. Chemical Research in Toxicology. 13(4). 294–300. 90 indexed citations
10.
Kopec, Karla & Richard T. Carroll. (1998). Alzheimer's β‐Amyloid Peptide 1–42 Induces a Phagocytic Response in Murine Microglia. Journal of Neurochemistry. 71(5). 2123–2131. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026